Info

The hedgehog was engaged in a fight with

Read More
Q&A

What does INTERMACS stand for?

What does INTERMACS stand for?

Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs)

Condition or disease Intervention/treatment
Cardiovascular Diseases Heart Diseases Heart Failure, Congestive Device: Mechanical Circulatory Support Device (MCSD)

When did INTERMACS start?

The Intermacs database, which began in 2006, became part of the Society of Thoracic Surgeons (STS) National database in 2018, is an interagency collaborative attempt to collect information about MCSD recipients for reasons of quality improvement.

What is LVAD in cardiology?

A left ventricular assist device (LVAD) is implanted in your chest. It helps pump blood from the left ventricle of your heart and on to the rest of your body. A control unit and battery pack are worn outside your body and are connected to the LVAD through a port in your skin.

What is the Forrester classification?

The more recent Diamond-Forrester classification defined four clinical subsets of shock: (I) no pulmonary congestion or peripheral hypoperfusion, (II) isolated pulmonary congestion, (III) isolated peripheral hypoperfusion, and (IV) both pulmonary congestion and hypoperfusion.

How long can you live with a LVAD pump?

A patient may stay alive for 5 and a half years with LVAD. As per research, 80–85% of patients are alive a year after having an LVAD placed and 70–75% of patients are alive for 2 years with an LVAD. Usually, patients without LVAD have a life expectancy of 12 months or less.

Are LVADs permanent?

A permanent LVAD is currently being used in some terminally ill patients whose condition makes them ineligible for heart transplantation. This is also called destination therapy.

What does HFpEF mean?

Heart failure with preserved ejection fraction (HFpEF): More than diastolic dysfunction.

When was HeartMate 3 approved for destination therapy?

ABBOTT PARK, Ill., Oct. 19, 2018 /PRNewswire/ — Abbott (NYSE: ABT) announced today that the HeartMate 3™ Left Ventricular Assist Device (LVAD) has received U.S. Food and Drug Administration (FDA) approval as a destination therapy for people living with advanced heart failure.

How long does LVAD extend life?

Left ventricular assist device (LVAD) is usually used to keep a patient alive until a suitable heart donor is found. A patient may stay alive for 5 and a half years with LVAD. As per research, 80–85% of patients are alive a year after having an LVAD placed and 70–75% of patients are alive for 2 years with an LVAD.